Sabra Health Care Insider: 367 dividend-equivalent units added to Flores' holdings

Rhea-AI Filing Summary

Sabra Health Care REIT insider filing: Jessica Flores, Executive VP & CAO, received 367 dividend-equivalent stock units on 08/29/2025 at no cash price; these units mirror dividend payments on previously granted stock units and will vest and be payable on the same terms as the original awards. After the reported transaction, Flores beneficially owns 73,286 shares/units, which include 23,709 stock units that will be settled one-for-one into shares upon settlement. The Form 4 was signed by an attorney-in-fact on 09/03/2025. No derivative securities are reported in this filing.

Positive

• 367 dividend-equivalent stock units were credited on 08/29/2025
• Reporting person now beneficially owns 73,286 shares/units, including 23,709 units payable one-for-one into common stock

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine compensation-related grant increases insider stake modestly; no cash paid and no derivatives reported.

The filing documents a standard dividend-equivalent credit of 367 stock units to an executive, recorded at a $0 price, consistent with equity compensation programs. The post-transaction beneficial ownership of 73,286 (including 23,709 units convertible one-for-one) modestly increases insider alignment with shareholders but does not reflect cash exercise or disposition activity. This is a non-material, routine disclosure absent other context.

Corporate Governance Expert

TL;DR: Typical disclosure of dividend equivalents under an incentive plan; vesting tied to original awards.

The report clarifies that the credited units are dividend equivalents tied to previously granted performance units under the 2009 Performance Incentive Plan and will vest on the same schedule as the underlying awards. Filing and signature by an attorney-in-fact are properly documented. There are no indications of accelerated vesting or unusual transactions in this Form 4.

Insider Trade Summary

Net Buyer: 367 shares

Net Buy 1 txn

Insider FLORES JESSICA

Role Executive VP & CAO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	367	$0.00	$0.00

Holdings After Transaction: Common Stock — 73,286 shares (Direct)

Footnotes (2)

1. F1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
2. F2. Includes 23,709 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 09/03/2025 - 02:10 PM Learn about SEC filing dates

FAQ

What did Jessica Flores report on Form 4 for SBRA?

The Form 4 reports that Jessica Flores received 367 dividend-equivalent stock units on 08/29/2025 and now beneficially owns 73,286 shares/units.

Were any cash purchases or sales reported in the SBRA Form 4?

No. The transaction is recorded at a $0 price and reflects dividend-equivalent stock units rather than a cash purchase or sale.

Do the credited units vest immediately according to the filing?

No. The filing states the units "will vest and become payable on the same terms as the original stock units" to which they relate.

How many of the reported units will convert into common stock?

The filing explicitly states it includes 23,709 stock units that, upon settlement, will be paid one-for-one in shares of the issuer's common stock.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by /s/ Michael Costa, as Attorney-in-Fact on 09/03/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLORES JESSICA

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CA 92782

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP & CAO

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		A		367(1)	A	$0	73,286(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

2. Includes 23,709 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Remarks:

	/s/ Michael Costa, as Attorney-in-Fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.